While the best companies are hard to find, but they can generate massive returns over long periods. To wit, the BioNTech SE ...
Google DeepMind by Alphabet Inc. (NASDAQ:GOOGL) (NASDAQ:GOOG) and BioNTech (NASDAQ:BNTX) are collaborating to develop AI lab ...
BioNTech has a broad and diversified cancer drug pipeline extending well beyond mRNA based approaches. Sam Fazeli, Senior Health Care Analyst, speaks to Ryan Richardson, Chief Strategy Officer, who ...
The BioNTech SE ADR BNTX advanced 2.40% to $122.68 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.90% to 5,751.07 and the ...
Company Conference Call October 1, 2024 9:00 AM ETCompany ParticipantsKarim Beguir - Chief Executive Officer, InstaDeepUğur ...
In a report released today, Yaron Werber from TD Cowen maintained a Hold rating on BioNTech SE (BNTX – Research Report), with a price ...
Provides updates on BioNTech’s strategy to scale and deploy AI-capabilities across the immunotherapy pipeline Highlights InstaDeep’s new near exascale supercomputer, Kyber, with the aim of ...
UBS analyst Eliana Merle maintained a Hold rating on BioNTech SE (BNTX – Research Report) today and set a price target of $131.00. The ...
Google DeepMind and BioNTech are building AI lab assistants to help researchers plan scientific experiments and better predict their outcomes as companies race to find specialised applications for ...
The BioNTech SE ADR BNTX rallied 1.59% to $117.64 Thursday, on what proved to be an all-around favorable trading session for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback